ACSL4 and metabolic dysfunction-associated steatotic liver disease: Alterations in ACSL4′s activity and expression contribute to the development and progression of various diseases, such as obesity, acute kidney injury (AKI), neurodegenerative diseases, cardiovascular diseases, exertional heat stroke, non-alcoholic fatty liver disease (NAFLD), and cancer (Table 3; Figure 8).